Registered Nurse in Sugarloaf Key, FL Accepting Medicare
1 Registered Nurse nurses found. Showing 1 - 1
 Ms. Margaret E Cooper, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 19591 Navajo St, Sugarloaf Key, FL 33042 Phone: 305-393-3086 |
News Archive
Tier 3 interventions needed to contain SARS-CoV-2 transmission, especially with emergence of variants
Studies have shown that non-pharmaceutical interventions (NPIs) such as social distancing and partial lockdowns effectively contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. However, because of these measures' huge economic and social cost, the UK introduced a less socially disruptive tier system. This system was aimed at providing a consistent set of control measures with geographic flexibility.
First-of-its kind study investigates effects of palliative care for medical decision-makers, caregivers
Shannon Carson, MD, professor of medicine and division chief of Pulmonary Diseases and Critical Care Medicine at the UNC School of Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study on the effects of palliative care for medical decision-makers.
Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration
Baxter International Inc. announced today that the U.S. Food and Drug Administration has approved the subcutaneous administration of GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] for patients with primary immunodeficiency.
Nimesulide fights breast cancer by targeting key enzyme
A pain-killing medication appears to halt the production of an enzyme that is key to a common form of breast cancer, a new study using tissue cultures suggests.
European authorisation of Aegerion Pharmaceuticals' Lojuxta brings hope for HoFH patients
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialisation of novel, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced today that the European Commission has authorised Lojuxta (lomitapide) hard capsules as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein apheresis in adult patients with homozygous familial hypercholesterolaemia.
› Verified 3 days ago